Find Research Outputs

Search concepts
Selected Filters
2018
4 Citations

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel

Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., Del Rio, C., Eron, J. J., Fätkenheuer, G., Günthard, H. F., Molina, J. M., Jacobsen, D. M. & Volberding, P. A., Jul 24 2018, In : JAMA - Journal of the American Medical Association. 320, 4, p. 379-396 18 p.

Research output: Contribution to journalArticle

HIV Infections
Antiviral Agents
HIV
Pharmaceutical Preparations
Therapeutics
5 Citations

A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients

Eron, J. J., Orkin, C., Gallant, J., Molina, J. M., Negredo, E., Antinori, A., Mills, A., Reynes, J., Van Landuyt, E., Lathouwers, E., Hufkens, V., Jezorwski, J., Vanveggel, S. & Opsomer, M., Jul 17 2018, In : AIDS. 32, 11, p. 1431-1442 12 p.

Research output: Contribution to journalArticle

Dilatation and Curettage
HIV-1
Tenofovir
Fumarates
Viral Load

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events

Haas, D. W., Bradford, Y., Verma, A., Verma, S. S., Eron, J. J., Gulick, R. M., Riddler, S. A., Sax, P. E., Daar, E. S., Morse, G. D., Acosta, E. P. & Ritchie, M. D., Jan 1 2018, In : Pharmacogenetics and Genomics. 28, 7, p. 179-187 9 p.

Research output: Contribution to journalArticle

efavirenz
Neurotransmitter Transport Proteins
Neurotransmitter Receptor
Genomics
Central Nervous System

Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV

Delaney, J. A., Nance, R. M., Whitney, B. M., Altice, F. L., Dong, X., Trejo, M. E. P., Matsuzaki, M., Taxman, F. S., Chander, G., Kuo, I., Fredericksen, R., Strand, L. N., Eron, J. J., Geng, E., Kitahata, M. M., Mathews, W. C., Mayer, K., Moore, R. D., Saag, M. S., Springer, S. & 3 othersChandler, R., Kahana, S. & Crane, H. M., Nov 1 2018, In : Journal of acquired immune deficiency syndromes (1999). 79, 3, p. 283-287 5 p.

Research output: Contribution to journalArticle

HIV
Depression
Amphetamine
Crack Cocaine
Cannabis

Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy

AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS), Jun 1 2018, In : PloS one. 13, 6, e0197665.

Research output: Contribution to journalArticle

HIV
therapeutics
neoplasms
viral load
Viral Load

Comparing neighborhood and state contexts for women living with and without HIV: understanding the Southern HIV epidemic

Ludema, C., Edmonds, A., Cole, S. R., Eron, J. J., Adedimeji, A. A., Cohen, J., Cohen, M. H., Kassaye, S., Konkle-Parker, D. J., Metsch, L. R., Wingood, G. M., Wilson, T. E. & Adimora, A. A., Jul 3 2018, (Accepted/In press) In : AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. p. 1-8 8 p.

Research output: Contribution to journalArticle

HIV
Medicaid
socioeconomic factors
health
Geographic Mapping
Tenofovir
HIV
Inflammation
RNA
HIV-1

Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model

for the CNICS Investigators, Jan 1 2018, In : Biometrical Journal. 60, 1, p. 100-114 15 p.

Research output: Contribution to journalArticle

Proportional Hazards Regression
Cox Regression
Hazard Models
Fixed Effects
Treatment Effects
1 Citations

Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework

for the CFAR Network of Integrated Clinical Systems, Feb 1 2018, In : American journal of epidemiology. 187, 2, p. 316-325 10 p.

Research output: Contribution to journalArticle

HIV
Population
Virus Diseases
Prescriptions
Acquired Immunodeficiency Syndrome

Generalizing evidence from randomized trials using inverse probability of sampling weights

Buchanan, A. L., Hudgens, M. G., Cole, S. R., Mollan, K. R., Sax, P. E., Daar, E. S., Adimora, A. A., Eron, J. J. & Mugavero, M. J., Oct 1 2018, In : Journal of the Royal Statistical Society. Series A: Statistics in Society. 181, 4, p. 1193-1209 17 p.

Research output: Contribution to journalArticle

Randomized Trial
Estimator
Target
evidence
Generalise

HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals

Sung, J. A., Patel, S., Clohosey, M. L., Roesch, L., Tripic, T., Kuruc, J. A. D., Archin, N. M., Hanley, P. J., Cruz, C. R., Goonetilleke, N. P., Eron, J. J., Rooney, C. M., Gay, C. L., Bollard, C. M. & Margolis, D. M., Oct 3 2018, In : Molecular Therapy. 26, 10, p. 2496-2506 11 p.

Research output: Contribution to journalArticle

Cell- and Tissue-Based Therapy
HIV
T-Lymphocytes
Safety
Therapeutics
1 Citations

HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015 a cohort study

Nance, R. M., Chris Delaney, J. A., Simoni, J. M., Wilson, I. B., Mayer, K. H., Whitney, B. M., Aunon, F. M., Safren, S. A., Mugavero, M. J., Christopher Mathews, W., Christopoulos, K. A., Eron, J. J., Napravnik, S., Moore, R. D., Rodriguez, B., Lau, B., Fredericksen, R. J., Saag, M. S., Kitahata, M. M. & Crane, H. M., Sep 18 2018, In : Annals of internal medicine. 169, 6, p. 376-384 9 p.

Research output: Contribution to journalReview article

Patient Care
Cohort Studies
HIV
Integrases
Viral Load
2 Citations

Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated during Acute HIV Infection

Gay, C. L., Debenedette, M. A., Tcherepanova, I. Y., Gamble, A., Lewis, W. E., Cope, A. B., Kuruc, J. D., McGee, K. S., Kearney, M. F., Coffin, J. M., Archin, N. M., Hicks, C. B., Eron, J. J., Nicolette, C. A. & Margolis, D. M., Jan 1 2018, In : AIDS Research and Human Retroviruses. 34, 1, p. 111-122 12 p.

Research output: Contribution to journalArticle

Cell- and Tissue-Based Therapy
Dendritic Cells
HIV Infections
T-Lymphocytes
HIV-1

Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States

Hartzler, B., Dombrowski, J. C., Williams, J. R., Crane, H. M., Eron, J. J., Geng, E. H., Mathews, C., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., Rodriguez, B. & Donovan, D. M., Mar 1 2018, In : AIDS and behavior. 22, 3, p. 742-751 10 p.

Research output: Contribution to journalArticle

HIV-2
Substance-Related Disorders
Age Groups
Cannabis
Ambulatory Care

Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015

Bengtson, A. M., Pence, B. W., Eaton, E. F., Edwards, J. K., Eron, J. J., Mathews, W. C., Mollan, K., Moore, R. D., O'Cleirigh, C., Geng, E. & Mugavero, M. J., Jan 1 2018, In : Antiviral Therapy. 23, 4, p. 363-372 10 p.

Research output: Contribution to journalArticle

efavirenz
Mental Health
Therapeutics
Health Status

Prevalence and transmission dynamics of HIV-1 transmitted drug resistance in a southeastern cohort

Levintow, S. N., Okeke, N. L., Hué, S., Mkumba, L., Virkud, A., Napravnik, S., Sebastian, J., Miller, W. C., Eron, J. J. & Dennis, A. M., Jan 1 2018, In : Open Forum Infectious Diseases. 5, 8, p. 1-10 10 p.

Research output: Contribution to journalArticle

Drug Resistance
HIV-1
Reverse Transcriptase Inhibitors
Mutation
Southeastern United States

Repeat testing of low-level HIV-1 RNA: Assay performance and implementation in clinical trials

White, K., Garner, W., Wei, L., Eron, J. J., Zhong, L., Miller, M. D., Martin, H., Plummer, A., Tran-Muchowski, C., Lindstrom, K., Porter, J., Piontkowsky, D., Light, A., Reiske, H. & Quirk, E., May 15 2018, In : AIDS. 32, 8, p. 1053-1057 5 p.

Research output: Contribution to journalArticle

Viremia
HIV-1
Viral Load
Clinical Trials
RNA

Sensitivity analyses for misclassification of cause of death in the parametric G-formula

Edwards, J. K., Cole, S. R., Moore, R. D., Mathews, W. C., Kitahata, M. & Eron, J. J., Jan 1 2018, In : American journal of epidemiology. 187, 8, p. 1808-1816 9 p.

Research output: Contribution to journalArticle

Cause of Death
Acquired Immunodeficiency Syndrome
HIV
Sensitivity and Specificity
Mortality
Rilpivirine
Tenofovir
Energy Intake
Tablets
HIV

T cells establish and maintain CNS viral infection in HIV-infected humanized mice

Honeycutt, J. B., Liao, B., Nixon, C. C., Cleary, R. A., Thayer, W. O., Birath, S. L., Swanson, M. D., Sheridan, P., Zakharova, O., Prince, F., Kuruc, J. A., Gay, C. L., Evans, C., Eron, J. J., Wahl, A. & Garcia, J. V., Jul 2 2018, In : Journal of Clinical Investigation. 128, 7, p. 2862-2876 15 p.

Research output: Contribution to journalArticle

Central Nervous System Viral Diseases
HIV
T-Lymphocytes
HIV Infections
Brain

Using Primer-ID Deep Sequencing to Detect Recent Human Immunodeficiency Virus Type 1 Infection

Dennis, A. M., Zhou, S., Sellers, C. J., Learner, E., Potempa, M., Cohen, M. S., Miller, W. C., Eron, J. J. & Swanstrom, R. I., Oct 20 2018, In : The Journal of infectious diseases. 218, 11, p. 1777-1782 6 p.

Research output: Contribution to journalArticle

High-Throughput Nucleotide Sequencing
Area Under Curve
HIV-1
RNA-Directed DNA Polymerase
Infection
1 Citations

Virologic suppression and CD4 + cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens

Edwards, J. K., Cole, S. R., Hall, H. I., Mathews, W. C., Moore, R. D., Mugavero, M. J. & Eron, J. J., Jan 14 2018, In : AIDS. 32, 2, p. 261-266 6 p.

Research output: Contribution to journalArticle

efavirenz
CD4 Lymphocyte Count
HIV
Therapeutics
Health Services Needs and Demand
2017
19 Citations

Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: A study by the Centers for AIDS Research Network of Integrated Clinical Systems

Feinstein, M. J., Nance, R. M., Drozd, D. R., Ning, H., Delaney, J. A., Heckbert, S. R., Budoff, M. J., Mathews, W. C., Kitahata, M. M., Saag, M. S., Eron, J. J., Moore, R. D., Achenbach, C. J., Lloyd-Jones, D. M. & Crane, H. M., Feb 1 2017, In : JAMA Cardiology. 2, 2, p. 155-162 8 p.

Research output: Contribution to journalArticle

Acquired Immunodeficiency Syndrome
Myocardial Infarction
HIV
Research
Viral Load
36 Citations

Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy

Gay, C. L., Bosch, R. J., Ritz, J., Hataye, J. M., Aga, E., Tressler, R. L., Mason, S. W., Hwang, C. K., Grasela, D. M., Ray, N., Cyktor, J. C., Coffin, J. M., Acosta, E. P., Koup, R. A., Mellors, J. W. & Eron, J. J., Jun 1 2017, In : Journal of Infectious Diseases. 215, 11, p. 1725-1733 9 p.

Research output: Contribution to journalArticle

HIV-1
Clinical Trials
Antibodies
Placebos
Therapeutics
1 Citations

Effects of Health Insurance Interruption on Loss of Hypertension Control in Women with and Women Without HIV

Edmonds, A., Ludema, C., Eron, J. J., Cole, S. R., Adedimeji, A. A., Cohen, M. H., Cooper, H. L., Fischl, M., Johnson, M. O., Krause, D. D., Merenstein, D., Milam, J., Wilson, T. E. & Adimora, A. A., Dec 1 2017, In : Journal of Women's Health. 26, 12, p. 1292-1301 10 p.

Research output: Contribution to journalArticle

Health Insurance
HIV
Hypertension
Confidence Intervals
Anti-HIV Agents
1 Citations

Health insurance type and control of hypertension among US women living with and without HIV infection in the women's interagency HIV study

Ludema, C., Cole, S. R., Eron, J. J., Holmes, G. M., Anastos, K., Cocohoba, J., Cohen, M. H., Cooper, H. L. F., Golub, E. T., Kassaye, S., Konkle-Parker, D., Metsch, L., Milam, J., Wilson, T. E. & Adimora, A. A., Jan 1 2017, In : American journal of hypertension. 30, 6, p. 594-601 8 p.

Research output: Contribution to journalArticle

Health Insurance
HIV Infections
HIV
Blood Pressure
Hypertension
14 Citations

HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers

Shiels, M. S., Althoff, K. N., Pfeiffer, R. M., Achenbach, C. J., Abraham, A. G., Castilho, J., Cescon, A., D'Souza, G., Dubrow, R., Eron, J. J., Gebo, K., Gill, M. J., Goedert, J. J., Grover, S., Hessol, N. A., Justice, A., Kitahata, M., Mayor, A., Moore, R. D., Napravnik, S. & 4 othersNovak, R. M., Thorne, J. E., Silverberg, M. J. & Engels, E. A., Feb 15 2017, In : Clinical Infectious Diseases. 64, 4, p. 468-475 8 p.

Research output: Contribution to journalArticle

Immunosuppression
HIV Infections
HIV
Acquired Immunodeficiency Syndrome
Neoplasms
2 Citations

Identifying HIV care enrollees at-risk for cannabis use disorder

Hartzler, B., Carlini, B. H., Newville, H., Crane, H. M., Eron, J. J., Geng, E. H., Mathews, W. C., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., Rodriguez, B. & Donovan, D. M., Jul 3 2017, In : AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 29, 7, p. 846-850 5 p.

Research output: Contribution to journalArticle

Cannabis
HIV
AIDS
sexual orientation
Demography
2 Citations

Incident AIDS or death after initiation of human immunodeficiency virus treatment regimens including raltegravir or efavirenz among adults in the United States

Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Investigators, Jan 1 2017, In : Clinical Infectious Diseases. 64, 11, p. 1591-1596 6 p.

Research output: Contribution to journalArticle

efavirenz
Acquired Immunodeficiency Syndrome
HIV
Confidence Intervals
Tenofovir

Increased Persistence of Initial Treatment for HIV Infection with Modern Antiretroviral Therapy

Davy-Mendez, T., Eron, J. J., Zakharova, O., Wohl, D. A. & Napravnik, S., Oct 1 2017, In : Journal of Acquired Immune Deficiency Syndromes. 76, 2, p. 111-115 5 p.

Research output: Contribution to journalArticle

HIV Infections
Integrases
Reverse Transcriptase Inhibitors
Therapeutics
Confidence Intervals
16 Citations

Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency

Archin, N. M., Kirchherr, J. L., Sung, J. A. M., Clutton, G., Sholtis, K., Xu, Y., Allard, B., Stuelke, E., Kashuba, A. D., Kuruc, J. D., Eron, J., Gay, C. L., Goonetilleke, N. & Margolis, D. M., Aug 1 2017, In : Journal of Clinical Investigation. 127, 8, p. 3126-3135 10 p.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
HIV
T-Lymphocytes
RNA
Infection
16 Citations

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

ACTG A5321 Team, Apr 1 2017, In : PLoS Pathogens. 13, 4, e1006285.

Research output: Contribution to journalArticle

HIV-1
Inflammation
Therapeutics
RNA
T-Lymphocytes
50 Citations

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Margolis, D. A., Gonzalez-Garcia, J., Stellbrink, H. J., Eron, J. J., Yazdanpanah, Y., Podzamczer, D., Lutz, T., Angel, J. B., Richmond, G. J., Clotet, B., Gutierrez, F., Sloan, L., Clair, M. S., Murray, M., Ford, S. L., Mrus, J., Patel, P., Crauwels, H., Griffith, S. K., Sutton, K. C. & 4 othersDorey, D., Smith, K. Y., Williams, P. E. & Spreen, W. R., Sep 23 2017, In : The Lancet. 390, 10101, p. 1499-1510 12 p.

Research output: Contribution to journalArticle

Rilpivirine
HIV Infections
HIV-1
Injections
Maintenance
5 Citations

mT-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

Thomas, A. S., Jones, K. L., Gandhi, R. T., McMahon, D. K., Cyktor, J. C., Chan, D., Huang, S. H., Truong, R., Bosque, A., Macedo, A. B., Kovacs, C., Benko, E., Eron, J. J., Bosch, R. J., Lalama, C. M., Simmens, S., Walker, B. D., Mellors, J. W. & Jones, R. B., Sep 1 2017, In : PLoS Pathogens. 13, 9, e1006629.

Research output: Contribution to journalArticle

HIV
T-Lymphocytes
HIV Antigens
Therapeutics
Clone Cells
3 Citations

Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016

Menza, T. W., Billock, R., Samoff, E., Eron, J. J. & Dennis, A. M., Oct 23 2017, In : AIDS. 31, 16, p. 2235-2244 10 p.

Research output: Contribution to journalArticle

Integrases
Mutation
HIV
Confidence Intervals
Genotype
8 Citations

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

Crane, H. M., McCaul, M. E., Chander, G., Hutton, H., Nance, R. M., Delaney, J. A. C., Merrill, J. O., Lau, B., Mayer, K. H., Mugavero, M. J., Mimiaga, M., Willig, J. H., Burkholder, G. A., Drozd, D. R., Fredericksen, R. J., Cropsey, K., Moore, R. D., Simoni, J. M., Christopher Mathews, W., Eron, J. J. & 5 othersNapravnik, S., Christopoulos, K., Geng, E., Saag, M. S. & Kitahata, M. M., Jul 1 2017, In : AIDS and behavior. 21, 7, p. 1914-1925 12 p.

Research output: Contribution to journalArticle

Odds Ratio
Alcohols
HIV
Binge Drinking
Therapeutics
8 Citations

Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States

Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron, J. J., Geng, E. H., Christopher Mathews, W., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., Rodriguez, B. & Donovan, D. M., Apr 1 2017, In : AIDS and behavior. 21, 4, p. 1138-1148 11 p.

Research output: Contribution to journalArticle

Substance-Related Disorders
HIV
Opiate Alkaloids
Geography
Methamphetamine
4 Citations

Race/ethnicity and the pharmacogenetics of reported suicidality with efavirenz among clinical trials participants

Mollan, K. R., Tierney, C., Hellwege, J. N., Eron, J. J., Hudgens, M. G., Gulick, R. M., Haubrich, R., Sax, P. E., Campbell, T. B., Daar, E. S., Robertson, K. R., Ventura, D., Ma, Q., Velez Edwards, D. R. & Haas, D. W., Sep 1 2017, In : Journal of Infectious Diseases. 216, 5, p. 554-564 11 p.

Research output: Contribution to journalArticle

efavirenz
Pharmacogenetics
Genotype
Clinical Trials
Suicidal Ideation

Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients

Fatukasi, T. V., Cole, S. R., Moore, R. D., Mathews, W. C., Edwards, J. K. & Eron, J. J., Jul 1 2017, In : PloS one. 12, 7, e0180843.

Research output: Contribution to journalArticle

risk factors
HIV
therapeutics
CD4 Lymphocyte Count
Therapeutics
1 Citations

The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care

Bengtson, A. M., Pence, B. W., Mollan, K. R., Edwards, J. K., Moore, R. D., O'Cleirigh, C., Eaton, E. F., Eron, J. J., Kitahata, M. M., Mathews, W. C., Crane, H. & Mugavero, M. J., Jan 1 2017, In : Journal of Acquired Immune Deficiency Syndromes. 76, 4, p. 402-408 7 p.

Research output: Contribution to journalArticle

efavirenz
HIV
Therapeutics
Confidence Intervals
1 Citations

The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals

Kim, H. N., Crane, H. M., Rodriguez, C. V., Van Rompaey, S., Mayer, K. H., Christopoulos, K., Napravnik, S., Chander, G., Hutton, H., McCaul, M. E., Cachay, E. R., Mugavero, M. J., Moore, R., Geng, E., Eron, J. J., Saag, M. S., Merrill, J. O. & Kitahata, M. M., Jul 1 2017, In : AIDS and behavior. 21, 7, p. 1878-1884 7 p.

Research output: Contribution to journalArticle

Fibrosis
Odds Ratio
Alcohols
HIV
Confidence Intervals
1 Citations
Clinical Trials
HIV
Tenofovir
Incidence
Virus Diseases
2016
1 Citations

Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results

Floris-Moore, M. A., Mollan, K., Wilkin, A. M., Johnson, M. A., Kashuba, A. D. M., Wohl, D. A., Patterson, K. B., Francis, O., Kronk, C. & Eron, J. J., Jan 1 2016, In : Antiviral Therapy. 21, 1, p. 55-64 10 p.

Research output: Contribution to journalArticle

etravirine
HIV
Safety
HIV-1
Tenofovir
217 Citations

Antiretroviral drugs for treatment and prevention of HIV infection in Adults: 2016 recommendations of the international antiviral society-USA Panel

Günthard, H. F., Saag, M. S., Benson, C. A., Del Rio, C., Eron, J. J., Gallant, J. E., Hoy, J. F., Mugavero, M. J., Sax, P. E., Thompson, M. A., Gandhi, R. T., Landovitz, R. J., Smith, D. M., Jacobsen, D. M. & Volberding, P. A., Jul 12 2016, In : JAMA - Journal of the American Medical Association. 316, 2, p. 191-210 20 p.

Research output: Contribution to journalArticle

HIV Infections
Antiviral Agents
HIV
Reverse Transcriptase Inhibitors
Pharmaceutical Preparations
5 Citations

Changes in clinical context for Kaposi's sarcoma and non-Hodgkin lymphoma among people with HIV infection in the United States

Yanik, E. L., Achenbach, C. J., Gopal, S., Coghill, A. E., Cole, S. R., Eron, J. J., Moore, R. D., Mathews, W. C., Drozd, D. R., Hamdan, A., Ballestas, M. E. & Engels, E. A., Sep 20 2016, In : Journal of Clinical Oncology. 34, 27, p. 3276-3283 8 p.

Research output: Contribution to journalArticle

Kaposi's Sarcoma
Non-Hodgkin's Lymphoma
HIV Infections
HIV
CD4 Lymphocyte Count
13 Citations

Continued slow decay of the residual plasma viremia level in HIV-1-infected adults receiving long-term antiretroviral therapy

Riddler, S. A., Aga, E., Bosch, R. J., Bastow, B., Bedison, M., Vagratian, D., Vaida, F., Eron, J. J., Gandhi, R. T. & Mellors, J. W., Feb 15 2016, In : Journal of Infectious Diseases. 213, 4, p. 556-560 5 p.

Research output: Contribution to journalArticle

Viremia
HIV-1
RNA
T-Lymphocytes
Therapeutics
4 Citations

Differential CD4+ cell count increase and CD4+: CD8+ ratio normalization with maraviroc compared with tenofovir

Chan, E. S., Landay, A. L., Brown, T. T., Ribaudo, H. J., Mirmonsef, P., Ofotokun, I., Weitzmann, M. N., Martinson, J., Klingman, K. L., Eron, J. J., Fichtenbaum, C. J., Plants, J. & Taiwo, B. O., Aug 24 2016, In : AIDS. 30, 13, p. 2091-2097 7 p.

Research output: Contribution to journalArticle

Tenofovir
CD4-CD8 Ratio
CD4 Lymphocyte Count
Cell Count
Biomarkers
4 Citations

Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level after Treatment Discontinuation

Bednar, M. M., Hauser, B. M., Zhou, S., Jacobson, J. M., Eron, J. J., Frank, I. & Swanstrom, R., Aug 1 2016, In : Journal of Infectious Diseases. 214, 3, p. 403-407 5 p.

Research output: Contribution to journalArticle

Tropism
HIV-1
Viruses
Population
Therapeutics
1 Citations

Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability

Gay, C. L., Willis, S. J., Cope, A. B., Kuruc, J. A. D., McGee, K. S., Sebastian, J., Crooks, A. M., McKellar, M. S., Margolis, D. M., Fiscus, S. A., Hicks, C. B., Ferrari, G. & Eron, J. J., Nov 28 2016, In : AIDS. 30, 18, p. 2815-2822 8 p.

Research output: Contribution to journalArticle

Tenofovir
efavirenz
HIV Infections
Therapeutics
Emtricitabine